Get the Stockscreener App
3.59
1.41%
0.05
After Hours:
3.66
0.07
+1.95%
Heartsciences Inc stock is traded at $3.59, with a volume of 126.39K.
It is up +1.41% in the last 24 hours and down -11.14% over the past month.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
See More
Previous Close:
$3.54
Open:
$3.58
24h Volume:
126.39K
Relative Volume:
1.24
Market Cap:
$8.06M
Revenue:
-
Net Income/Loss:
$-7.29M
P/E Ratio:
-0.1473
EPS:
-24.3686
Net Cash Flow:
$-6.81M
1W Performance:
+17.70%
1M Performance:
-11.14%
6M Performance:
-5.58%
1Y Performance:
+12.19%
1-Day Range:
$3.4216
$3.68
1-Week Range:
$3.09
$3.75
52-Week Range:
$2.36
$6.47
Heartsciences Inc Stock (HSCS) Company Profile
Name
Heartsciences Inc
Sector
Industry
Phone
682-237-7781
Address
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.59 | 7.85M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Heartsciences Inc Stock (HSCS) Latest News
Quant Models Detect Momentum Reversal in HeartSciences Inc.Beginner Friendly Stock Selection Guide Updated - beatles.ru
HeartSciences expands equity distribution agreement to $25 million with Maxim Group - Investing.com Nigeria
What are analysts’ price targets for HeartSciences Inc. in the next 12 monthsBreakout stock performance - Jammu Links News
When is HeartSciences Inc. stock expected to show significant growthPhenomenal capital gains - Jammu Links News
Is it the right time to buy HeartSciences Inc. Equity Warrant stockCapitalize on strong market momentum - Jammu Links News
How strong is HeartSciences Inc. company’s balance sheetGet real-time alerts on top-performing stocks - Jammu Links News
How volatile is HeartSciences Inc. Equity Warrant stock compared to the marketHigh-octane investment opportunities await - Jammu Links News
What are the technical indicators suggesting about HeartSciences Inc.Robust investment performance - Jammu Links News
Should I hold or sell HeartSciences Inc. stock in 2025Unlock powerful trading tools for investors - Jammu Links News
What analysts say about HeartSciences Inc. stockMaximize returns with strategic portfolio planning - Jammu Links News
How does HeartSciences Inc. Equity Warrant generate profit in a changing economyDynamic portfolio growth - Jammu Links News
How does HeartSciences Inc. generate profit in a changing economyGet daily updates on promising stocks - Jammu Links News
Should I hold or sell HeartSciences Inc. Equity Warrant stock in 2025Unbelievable profit margins - Jammu Links News
What is the dividend policy of HeartSciences Inc. stockProven strategies for superior portfolio growth - Jammu Links News
What are HeartSciences Inc. Equity Warrant company’s key revenue driversGet alerts on the hottest stocks daily - Jammu Links News
Is HeartSciences Inc. Equity Warrant a good long term investmentCapitalize on proven investment strategies - Jammu Links News
What is the risk reward ratio of investing in HeartSciences Inc. Equity Warrant stockExplosive trading opportunities - Jammu Links News
Published on: 2025-08-03 10:19:05 - beatles.ru
What are the latest earnings results for HeartSciences Inc.Maximize returns with disciplined trading approaches - Jammu Links News
What is the risk reward ratio of investing in HeartSciences Inc. stockCapitalize on emerging trends for profits - Jammu Links News
How many analysts rate HeartSciences Inc. Equity Warrant as a “Buy”Get alerts on high-potential market moves - Jammu Links News
When is HeartSciences Inc. Equity Warrant stock expected to show significant growthMaximize your portfolio’s growth potential - Jammu Links News
What drives HeartSciences Inc. Equity Warrant stock priceTremendous growth potential - Jammu Links News
What are HeartSciences Inc. company’s key revenue driversFastest-growing stock picks - Jammu Links News
How volatile is HeartSciences Inc. stock compared to the marketDiscover hidden gems in the stock market - Jammu Links News
Comparing HeartSciences Inc. in custom built stock radarsVolume Spike Detection for Early Breakouts - Newser
Applying sector rotation models to HeartSciences Inc.Day Trading Setup Forecast with Trend Model - Newser
Why HeartSciences Inc. stock attracts strong analyst attentionWeekly Stock Picks with Trend Confidence - Newser
HeartSciences (HSCS) Projected to Post Quarterly Earnings on Monday - Defense World
What makes HeartSciences Inc. stock price move sharplySafe Entry Strategy with High Win Rate - Newser
Predicting HeartSciences Inc. Equity Warrant trend using moving averagesStrategy Chart for Real-Time Trade Flow - Newser
Is HeartSciences Inc. building a consolidation baseHigh Reward Picks with Tight Risk Control - Newser
HeartSciences Inc. Equity Warrant recovery potential after sell offFree High Growth Low Risk Stock Selection - Newser
HeartSciences Inc. Equity Warrant Company’s Quarterly Earnings Growth: What the Numbers SayControlled Entry Strategy With Safety Analytics - Newser
Technical signs of recovery in HeartSciences Inc.High Win Rate Strategy with Stop Protection - Newser
What makes HeartSciences Inc. Equity Warrant stock price move sharplyFree Risk Controlled Picks With Real Returns - Newser
News impact scoring models applied to HeartSciences Inc. Equity WarrantFree Real Time Stock Movement Analysis - Newser
Does HeartSciences Inc. fit your quant trading modelDownside Control Plan With Support Analysis - Newser
Risk adjusted return profile for HeartSciences Inc. analyzedFree Breakout Momentum Picks With Protection - Newser
Heart Test Laboratories Raises $4.3 Million in Regulation A Offering, Issues Units and Converts Debt - AInvest
Does HeartSciences Inc. stock perform well during market downturnsStock Market Forecasts For 2025 - Jammu Links News
Has HeartSciences Inc. formed a bullish divergenceDownside Control Plan With Support Analysis - Newser
Heartsciences’ director Hilz sells $15,621 in shares By Investing.com - Investing.com South Africa
Heartsciences Inc Stock (HSCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):